Klevens RM, Hu DJ, Jiles R, Holmberg SD. Evolving epidemiology of hepatitis C virus in the United States. Clin Infect Dis. 2012;55(Suppl 1):S3-9.
Hagan H, Pouget ER, Des Jarlais DC, Lelutiu-Weinberger C. Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. Am J Epidemiol. 2008;168:1099–109.
Article PubMed PubMed Central Google Scholar
Suryaprasad AG, White JZ, Xu F, Eichler B-A, Hamilton J, Patel A, et al. Emerging epidemic of Hepatitis C Virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin Infect Dis. 2014;59:1411–9.
Article CAS PubMed Google Scholar
Zibbell JE, Asher AK, Patel RC, Kupronis B, Iqbal K, Ward JW, et al. Increases in acute Hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108:175–81.
Article PubMed PubMed Central Google Scholar
Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr. 2016;73:323–31.
Article PubMed PubMed Central Google Scholar
Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis. 2002;186:1558–64.
Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002;155:645–53.
Hagan H, Pouget ER, Williams IT, Garfein RL, Strathdee SA, Hudson SM, et al. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. J Infect Dis. 2010;201:378–85.
Maher L, Jalaludin B, Chant KG, Jayasuriya R, Sladden T, Kaldor JM, et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction. 2006;101:1499–508.
Mackesy-Amiti ME, Donenberg GR, Ouellet LJ. Prevalence of psychiatric disorders among young injection drug users. Drug Alcohol Depend. 2012;124:70–8.
Article PubMed PubMed Central Google Scholar
Sansone RA, Whitecar P, Wiederman MW. The prevalence of childhood trauma among those seeking buprenorphine treatment. J Addict Dis. 2009;28:64–7.
McCauley JL, Killeen T, Gros DF, Brady KT, Back SE. Posttraumatic stress disorder and co-occurring substance use disorders: advances in assessment and treatment. Clin Psychol. 2012;19:283–304.
Winstanley EL, Mahoney JJ 3rd, Lander LR, Berry JH, Marshalek P, Zheng W, et al. Something to despair: Gender differences in adverse childhood experiences among rural patients. J Subst Abuse Treat. 2020;116:108056.
Article PubMed PubMed Central Google Scholar
Adams M, Sionean C, Broz D, Lewis R, Wejnert C, NHBS Study Group. Serious mental illness among young people who inject drugs: an assessment of injection risks and healthcare use. J Infect Dis. 2020;222(Suppl 5):S401-9.
Wild TC, Cameron Wild T, el-Guebaly N, Fischer B, Brissette S, Brochu S, et al. Comorbid depression among untreated illicit opiate users: results from a multisite Canadian Study. Canadian J Psychiatr. 2005;50:512–8.
Perdue T, Hagan H, Thiede H, Valleroy L. Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. AIDS Educ Prev. 2003;15:81–92.
Mandell W, Kim J, Latkin C, Suh T. Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. Am J Drug Alcohol Abuse. 1999;25:117–27.
Article CAS PubMed Google Scholar
Williams SC, Davey-Rothwell MA, Tobin KE, Latkin C. People who inject drugs and have mood disorders—a brief assessment of health risk behaviors. Subst Use Misuse. 2017;52:1175–84.
Mackesy-Amiti ME, Donenberg GR, Ouellet LJ. Psychiatric correlates of injection risk behavior among young people who inject drugs. Psychol Addict Behav. 2014;28:1089–95.
Article PubMed PubMed Central Google Scholar
Latkin CA, Mandell W. Depression as an antecedent of frequency of intravenous drug use in an urban, nontreatment sample. Int J Addict. 1993;28:1601–12.
Article CAS PubMed Google Scholar
Lemstra M, Rogers M, Thompson A, Moraros J, Buckingham R. Risk indicators of depressive symptomatology among injection drug users and increased HIV risk behaviour. Can J Psychiatry. 2011;56:358–66.
Huang C, Yuan Q, Zhang L, Wang L, Cui S, Zhang K, et al. Associations between childhood trauma and the age of first-time drug use in methamphetamine-dependent patients. Front Psychiatry. 2021;12:658205.
Article PubMed PubMed Central Google Scholar
Ompad DC, Ikeda RM, Shah N, Fuller CM, Bailey S, Morse E, et al. Childhood sexual abuse and age at initiation of injection drug use. Am J Public Health. 2005;95:703–9.
Article PubMed PubMed Central Google Scholar
Taplin C, Saddichha S, Li K, Krausz MR. Family history of alcohol and drug abuse, childhood trauma, and age of first drug injection. Subst Use Misuse. 2014;49:1311–6.
Battjes RJ, Leukefeld CG, Pickens RW. Age at first injection and HIV risk among intravenous drug users. Am J Drug Alcohol Abuse. 1992;18:263–73.
Article CAS PubMed Google Scholar
White RH, O’Rourke A, Kilkenny ME, Schneider KE, Weir BW, Grieb SM, et al. Prevalence and correlates of receptive syringe-sharing among people who inject drugs in rural Appalachia. Addiction. 2021;116:328–36.
el-Serag HB, Kunik M, Richardson P, Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002;123:476–82.
Girardin F, Painter C, Hearmon N, Eddowes L, Kaiser S, Negro F, et al. Hepatitis C prevalences in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapy. JHEP Rep. 2021;3:100279.
Article PubMed PubMed Central Google Scholar
Hughes E, Bassi S, Gilbody S, Bland M, Martin F. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis. Lancet Psychiatr. 2016;3:40–8.
Lerner AM, Fauci AS. Opioid injection in rural areas of the United States: a potential obstacle to ending the HIV epidemic. JAMA. 2019;322:1041–2.
Wagner K, Zhong Y, Teshale E, White K, Winstanley EL, Hettema J, et al. Hepatitis C virus infection and polysubstance use among young adult people who inject drugs in a rural county of New Mexico. Drug Alcohol Depend. 2021;220:108527.
Article CAS PubMed PubMed Central Google Scholar
Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702–6.
Agresti A. An introduction to categorical data analysis. Hoboken: John Wiley & Sons; 2018.
Lin DY, Wei LJ, Ying Z. Model-checking techniques based on cumulative residuals. Biometrics. 2002;58:1–12.
Article CAS PubMed Google Scholar
Dziak JJ, Coffman DL, Lanza ST, Li R, Jermiin LS. Sensitivity and specificity of information criteria. Brief Bioinform. 2020;21:553–65.
Muthén B, Muthén L. Mplus. Boca Raton: Chapman and Hall/CRC; 2017.
Najavits LM, Weiss RD, Shaw SR. The link between substance abuse and posttraumatic stress disorder in women. Res Rev Am J Addict. 1997;6:273–83.
Plotzker RE, Metzger DS, Holmes WC. Childhood sexual and physical abuse histories, PTSD, depression, and HIV risk outcomes in women injection drug users: a potential mediating pathway. Am J Addict. 2007;16:431–8.
Mitra S, Lee W, Hayashi K, Boyd J, Milloy MJ, Dong H, et al. A gender comparative analysis of post-traumatic stress disorder among a community-based cohort of people who use drugs in Vancouver. Canada Addict Behav. 2021;115: 106793.
Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2006;67:247–57.
Article CAS PubMed Google Scholar
Reddon H, Pettes T, Wood E, Nosova E, Milloy M-J, Kerr T, et al. Incidence and predictors of mental health disorder diagnoses among people who inject drugs in a Canadian setting. Drug Alcohol Rev. 2018;37(Suppl 1):S285–93.
留言 (0)